Trouble reading this email? View it in your browser
European Federation of Pharmaceutical Industries and Associations EFPIA Newsletter 02 July 2020
      EU Pharmaceutical Strategy could be a lost opportunity if action is not taken now
 
 
Parliament Magazine
 
When the Roadmap to the EU’s Pharmaceutical strategy was announced by Health Commissioner Stella Kyriakides, she underlined that “The EU needs a pharmaceutical strategy that makes essential medicines available to all and cements our global leadership on innovation in pharmaceuticals”. Now more than ever before, the COVID-19 crisis has shown that the world looks to medical innovation to fight global health threats and to tackle our existing health challenges. In its current form, the pharma strategy roadmap lacks the necessary drivers of innovation to put Europe back at the forefront of medical discovery.
Read more →
 
 
      News
 
  02 July 2020 Time to act together: patients wait more than 6 times longer for access to new medicines in...

The EFPIA Patients WAIT Survey and the EFPIA/CRA analysis should serve as a starting point for an informed discussion...

Read more →
 
 
 
  30 June 2020 EFPIA announces new members at a critical time for European healthcare and the research-based...

EFPIA welcomes Stallergenes Greer Ltd and Gilead Sciences as new members of EFPIA, as well as 14 new SME members and...

Read more →
 
 
 
      Blogs
 
  30 June 2020 Make the regulatory system fit for the future of medical innovation

The “new normal” in regulatory terms should aim at decreasing complexity while ensuring the quality, safety and efficacy...

Read more →
 
 
 
  29 June 2020 ICH - Instilling ‘harmony’ for 30 years, and never more relevant than today!

Harmonisation of requirements for drug development and manufacturing will contribute to the objective of safe, effective...

Read more →
 
 
 
      Videos
 
 
 
Keep the Spark Alive: the Regulatory Road to Innovation
Europe’s regulatory system is designed to ensure that new treatments for patients are safe and effective. It has helped to extend and improve the lives of millions of people across Europe and beyond. More can be done to keep pace with developments in science and technology, so that we can deliver safe medicines to patients faster than we've ever done before.
 
 
Treatment Outcomes 2020/30
This international conference, organized under the patronage of the Presidency of the Council of the European Union, will host leading experts in the field of monitoring treatment outcomes and transforming the health systems towards validating quality of care for patients.
 
 
 
 
      Our latest publications
2020: The Pharmaceutical Industry in Figures 30 June 2020 (Publications)
Our annual statistics leaflet
Read more →
EFPIA Patients W.A.I.T. Indicator 2019 Survey 01 July 2020 (Publications)
The yearly EFPIA Patients WAIT survey is now published
Read more →
The root causes of unavailability and delay to innovative medicines 01 July 2020 (Publications)
Analysis developed with the support of Charles Rivers Associates (CRA)
Read more →
 
      What we are reading
IMI-supported Ebola vaccine regimen gets green light 01 July 2020  (IMI website) Read more →
    About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

 
Tel: +32 (0)2 626 25 55
Communications@efpia.eu
▶ in
 
EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe